TheraThera
 
TheraThera
  • Home
  • The Firm
    • About Us
    • Thera Team
    • Thera Experts Network – TEN
    • Alliances
      • Knight & Pawn – Global Strategic Communications
      • Cabildum Consulting – Public Affairs and Health Policies – Mexico/LATAM
    • TheraTalks
      • Episode 1 – Global Pharma Supply Chain Resilience with Archana Jatkar (IPA) – July 20th, 2026
  • Our Expertise
    • Our Services
    • What We Deliver
  • Projects
    • Topics
      • Disease-related
        • Asthma
        • Cancer
        • Cardiovascular-Reno-Metabolic
        • COPD
        • Huntington’s Disease
        • Migraine
        • Mental Health
        • Obesity
        • Rare diseases
        • Schizophrenia
        • Women’s health
      • Structural
        • Adherance to Therapy
        • Antimicrobial Resistance
        • Artificial Intelligence and Its Impact on Health
        • Biosimilars
        • Complex Generics
        • Digital Health
        • Effective Access
        • Evidence-based Health Policies
        • Lifecycle of Medicines
        • Patient Participation
        • Pharmaceutical Relocation
        • Precision Medicine
        • Regulatory Convergence & Harmonization
        • Substandard Medicines
        • Unfair Competition
        • Value in Health
    • Documents
      • Policy papers
      • Columns
        • Adherence to therapy: the final and fundamental link-broken – El Economista
        • Antimicrobial Resistance: The Silent Pandemic – El Economista
        • Artificial Intelligence and Its Impact on Health – El Economista
        • Biosimilars LATAM – El Economista
        • Cardio-Reno-Metabolic Axis – El Economista
        • Complex Generics – El Economista
        • COPD set to become the third leading cause of death – El Economista
        • Digital Health – El Economista
        • Health Policies without Evidence – El Economista
        • Huntington disease: A rare condition – El Economista
        • Mental Health OECD 2025 – El Economista
        • Migraine – El Economista
        • Obesity – El Economista
        • Patient Paticipation in Health Decision-Making – El Economista
        • Pharmaceutical Relocation – El Economista
        • Precision medicine – Latin America is already practicing it whether it has decided to or not – El Economista
        • Regulatory Convergence & Harmonization – El Economista
        • Schizophrenia: the cost of silence and the value of action – El Economista
        • Substandard medicines and competition: An ongoing effort – El Economista
        • The Lifecycle of Medicines: Understanding it is Maximizing Access – El Economista
        • Unfair Competition – El Economista
        • Value in Health – El Economista
        • When Health Systems promise but fail to deliver – El Economista
        • Women’s Health Gaps – El Economista
        • World Asthma Day – El Economista
        • World Cancer Day 2026 – El Economista
        • World Rare Disease Day 2026 – El Economista
  • News
    • About Thera
      • Thera Health Policy & Access and Cabildum Consulting launch strategic alliance to advance healthcare access and system transformation across Latin America – July 24, 2026
      • TheraTalks debuts with an exclusive interview featuring Archana Jatkar of the Indian Pharmaceutical Alliance – July 20th, 2026
      • Knight & Pawn and Thera Health Policy & Access launch strategic alliance to advance healthcare value creation – July 2026
      • Thera launches – July 1, 2026
      • Thera’s Managing Director discusses biosimilars and USMCA review with El Economista – July 2026
    • Health Policy & Systems
      • ALIFAR 2026
      • Column on Cardio-Reno-Metabolic Syndrome – El Economista, June 10th, 2026
    • Market Access
      • Thera publishes new opinion article on Precision Medicine in Latin America a policy: agenda already underway – July 17th, 2026
      • Thera Health Policy Participates in CEPA Chile-India technical roundtable – June 18th, 2026
      • Column Biosimilars LATAM – El Economista, April 10th, 2026
      • Column Unfair Competition – El Economista, April 30th, 2026
    • Legal & Regulatory
      • Chiles competition authority launches new market study on pharmaceuticals – June 19th, 2026
    • Multi-Stakeholders Collaboration
  • Ethics & Compliance

https://thera-hpa.com/wp-content/uploads/2026/05/Footer-2-pdf.jpg
Contact the Firm

©2026 THERA Health Policy & Access. All rights reserved.

  • Privacy Policy
  • Cookie Policy